Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$83.3M |
| 2 |
Bank of America
BAC
|
+$60.7M |
| 3 |
Wells Fargo
WFC
|
+$46.3M |
| 4 |
Citigroup
C
|
+$33.4M |
| 5 |
US Bancorp
USB
|
+$18.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$535M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$484M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$386M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$74.6M |
| 5 |
Biogen
BIIB
|
+$55.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.62% |
| 2 | Consumer Discretionary | 3.62% |
| 3 | Industrials | 2.16% |
| 4 | Materials | 1.56% |
| 5 | Technology | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Akamai
AKAM
$16.1B
| – | – |
-53,107
| Closed | -$4.85M |
|
477
AMC Global Media
AMCX
$489M
| – | – |
-13,820
| Closed | -$679K |
|
478
American Tower
AMT
$80.4B
| – | – |
-98,842
| Closed | -$21.9M |
|
479
American Water Works
AWK
$26.9B
| – | – |
-2,254
| Closed | -$280K |
|
480
American Express
AXP
$230B
| – | – |
-48,583
| Closed | -$5.75M |
|
|
481
Biogen
BIIB
$30.7B
| – | – |
-237,455
| Closed | -$55.3M |
|
482
Booking.com
BKNG
$161B
| – | – |
-108,575
| Closed | -$8.52M |
|
483
Bristol-Myers Squibb
BMY
$132B
| – | – |
-219,568
| Closed | -$11.1M |
|
484
Berkshire Hathaway Class B
BRK.B
$1.13T
| – | – |
-109,054
| Closed | -$22.7M |
|
485
Boston Scientific
BSX
$71.5B
| – | – |
-26,571
| Closed | -$1.08M |
|
486
Boston Properties
BXP
$11.1B
| – | – |
-67,657
| Closed | -$8.77M |
|
487
CACI
CACI
$14.2B
| – | – |
-1,314
| Closed | -$304K |
|
488
Cardinal Health
CAH
$55.4B
| – | – |
-349,452
| Closed | -$16.5M |
|
489
Cheesecake Factory
CAKE
$5.33B
| – | – |
-12,507
| Closed | -$521K |
|
490
CF Industries
CF
$17.3B
| – | – |
-228,328
| Closed | -$11.2M |
|
491
Colgate-Palmolive
CL
$74.4B
| – | – |
-20,802
| Closed | -$1.53M |
|
492
Cleveland-Cliffs
CLF
$6.99B
| – | – |
-4,081,690
| Closed | -$29.5M |
|
493
Clorox
CLX
$12.7B
| – | – |
-180,535
| Closed | -$27.4M |
|
494
Comcast
CMCSA
$90B
| – | – |
-493,221
| Closed | -$22.2M |
|
495
Chipotle Mexican Grill
CMG
$41.5B
| – | – |
-203,400
| Closed | -$3.42M |
|
496
CenterPoint Energy
CNP
$26.8B
| – | – |
-230,529
| Closed | -$6.96M |
|
497
CNX Resources
CNX
$5.2B
| – | – |
-1,348,555
| Closed | -$9.79M |
|
498
Cencora
COR
$61.2B
| – | – |
-399,252
| Closed | -$32.9M |
|
499
Charles River Laboratories
CRL
$12.8B
| – | – |
-3,406
| Closed | -$451K |
|
500
Cisco
CSCO
$479B
| – | – |
-68,892
| Closed | -$3.4M |
|
Similar funds
Ray Dalio's Q4 2019 Portfolio in Review
As of Q4 2019, Ray Dalio held 589 positions worth $9.79B, down 14% from $11.4B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Ray Dalio withdrew a net $2.32B in Q4 2019, closing 118 positions and reducing 104 holdings. Its most notable exit was Biogen, an estimated $55.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 6.6% of assets, up from 3.2% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Ray Dalio opened a new position in JPMorgan Chase worth $90.5M.
- Ray Dalio's largest Q4 2019 buy was JPMorgan Chase: 649,376 shares worth $90.5M.
- Ray Dalio added most to iShares MSCI Taiwan ETF in Q4 2019, an estimated $16.2M increase.
- Ray Dalio's biggest Q4 2019 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $535M.
- Ray Dalio fully exited Biogen in Q4 2019, selling an estimated $55.3M.
- Ray Dalio's ten largest holdings make up 67% of its $9.79B portfolio in Q4 2019.
- Ray Dalio opened 256 new positions and closed 118 in Q4 2019.
- Ray Dalio's portfolio value fell 14% quarter-over-quarter to $9.79B.
Based on Bridgewater Associates's 13F filing for Q4 2019, filed 13 Feb 2020.